We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Premature Neonates Breathe Easier with Less Invasive Therapy

By HospiMedica International staff writers
Posted on 10 Oct 2011
A new study claims that delivering a surfactant though a thin catheter to premature babies with respiratory distress syndrome (RDS) helps them breathe better, reducing the need for mechanical ventilation.

Researchers at the University of Lübeck (Germany), the University of Cologne (Germany) and other institutions in the German Neonatal Network conducted a randomized trial involving 220 infants with a gestational age of 26-28 weeks and a birth weight less than 1.5 kg that were assigned to standard treatment (112 infants) or to intervention via catheter-delivered surfactant (108 infants), if they developed RDS. More...
The primary outcome was the need for any mechanical ventilation, or not being ventilated but having a partial pressure of carbon dioxide (CO2) greater than 65 mm Hg or a fraction of inspired oxygen more than 0.60 for more than two hours, between 25 and 72 hours of age.

The researchers found that on the second or third day after birth, 30 infants (28%) in the intervention group were mechanically ventilated, compared with 51 (46%) in the standard treatment group, which yielded a significant absolute risk reduction of 0.18. Over the whole length of stay, 33% of infants in the intervention group were mechanically ventilated compared with 73% in the standard treatment group. The intervention group also had significantly fewer median days on mechanical ventilation and a lower need for oxygen therapy at 28 days. There were seven deaths and 21 serious adverse events in the intervention group, compared to five deaths and 28 adverse events in the standard treatment group, which was not significantly different. The study was published early online on September 30, 2011, in the Lancet.

“When the study was planned five years ago, this was not existing practice in the majority of neonatal intensive care units in Germany, but numbers of treated infants have rapidly increased,” said corresponding author professor of pediatrics Egbert Herting, PhD, of the University of Lübeck. “Some 20% to 30% of surfactant applications are done now that way in Germany, with increasing interest from all over the world.”

Standard treatment for RDS is to deliver surfactant via endotracheal tube during mechanical ventilation. To avoid the risks of endotracheal intubation, continuous positive airway pressure (CPAP) and noninvasive mechanical ventilation have been used; CPAP alone, however, has had the disadvantage of not allowing delivery of surfactant to these preterm neonates. The study shows that the application of surfactant via a thin catheter to spontaneously breathing preterm infants receiving CPAP reduces the need for mechanical ventilation.

Related Links:

University of Lübeck
University of Cologne



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ultrasound Needle Guidance System
SonoSite L25
LED Surgical Lamp
ACEMST35/57
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.